Tweets
đź“Š SIJ findings in PsA (n=581):
🧠31% = MRI-confirmed axSpA
🦴 Only 29% met r-mNY criteria
MRI-axPsA group: younger, more male, HLA-B27+
Clinical + radiographic definitely underperform vs MRI
#POS0297 @RheumNow #EULAR2025
Jiha Lee @JihaRheum ( View Tweet )
10 months 2 weeks ago
PsO + recent arthralgia—but no PsA. Treat or wait?
🧠18% developed PsA in 3 yrs, most in year 1
🔍 Predictors: tender joints, disability, enthesis erosion
Consider early rheum input for these patients
Abstract POS0299 @RheumNow #EULAR2025
Jiha Lee @JihaRheum ( View Tweet )
10 months 2 weeks ago
Can RZB deliver in real-world early PsA?
đź’Ą 9-month results say yes:
âś… Dactylitis gone in 79%
âś… Enthesitis in 90%
âś… 97% MDs & 88% pts satisfied
Early intervention may pay off.
Abstract POS0304 @RheumNow #EULAR2025
Jiha Lee @JihaRheum ( View Tweet )
10 months 2 weeks ago
Very pleased to present at #EULAR2025 work @ArthritisAust on consumer involvement into research.
Consumer involvement in research delivers:
- better, more relevant research
- better dissemination of results
- competitiveness in today’s funding landscape
POS1016-PARE @RheumNow https://t.co/0fhpsnGhdT
David Liew @drdavidliew ( View Tweet )
10 months 2 weeks ago
High dose NSAIDs and incidence of HTN in axSpA?
In pts with early axSpA(age at baseline 33.2 years) data from DESIR cohort showed that after adjusting for confounders,high dose NSAID use was not associated with incident hypertension (HR 1.01, 95% CI 0.98-1.02).
Interesting to
Adela Castro @AdelaCastro222 ( View Tweet )
10 months 2 weeks ago
Rheumatoid nodules are fascinating. If methotrexate nodulosis is a factor, why has their rate gone down when MTX use has gone up?
Environmental factors? Something else? It’s still a bit of a mystery - we still don’t know why
Christopher Edwards #EULAR2025 @RheumNow https://t.co/8LJYNRybve
Links:
David Liew @drdavidliew ( View Tweet )
10 months 2 weeks ago
Maybe the pathogenesis gives us a clue on how to target things?
Possibly the treatments which take down synovitis might not always help with nodules
Christopher Edwards #EULAR2025 @RheumNow https://t.co/T6QHCS8709
Links:
David Liew @drdavidliew ( View Tweet )
10 months 2 weeks ago
#EULAR2025 Abstr#POS0320 Data from TULIP+LTE compared to Lupus Toronto Cohort as Control showed Anifrolumab reduced organ damage progression up to 4 years vs real-world SOC in #SLE. Effect continued to 10yrs using novel extrapolate analysis @RheumNow https://t.co/bkjZCZ8xGr
Md Yuzaiful Md Yusof @Yuz6Yusof ( View Tweet )
10 months 2 weeks ago
What is new in SpA?
‼️nomenclature change:
🚫AS≠Ankylosing spondylitis
âś…AS= Axial spondyloarthritis
-Helena Marzo-Ortega at #EULAR2025
@RheumNow
Adela Castro @AdelaCastro222 ( View Tweet )
10 months 2 weeks ago
Delay hurts.
Dx delay in axial SpA costs UK ÂŁ3.1 billion annually.
Avg time to dx = 8.5 yrs
Avg dx cost = ÂŁ187k/person
Fixing delay could save ÂŁ167k/person.
Early Dx isn’t just better care—it’s economic policy.
#EULAR2025 @RheumNow
#AxialSpA #RMD https://t.co/eYEQ2rp94m
Jiha Lee @JihaRheum ( View Tweet )
10 months 2 weeks ago
@RheumNow So rheumatoid nodule treatment might target some of that pathophysiology. Rituximab, abatacept, or JAKi?
And while surgery often isn’t great (plus they often grow back), definitely an option for some.
Christopher Edwards #EULAR2025 @RheumNow https://t.co/sFWnQN8uC4
Links:
David Liew @drdavidliew ( View Tweet )
10 months 2 weeks ago
#Psoriatic_Arthritis
#Preclinical #Early
❓️ Does joint swelling occur in the same anatomical locations affected in the subclinical phase?
🅰️ Yes, in 68%
🅰️ Especially if positive ultrasound
#EULAR2025
@RheumNow
OP0179 by Ivan Giivannini et al. https://t.co/rKfreQyJeG
Nelly ZIADE 🍀 @Nellziade ( View Tweet )
10 months 2 weeks ago
